Joacim Holter

Borea Asset Management AS (Borea) is the investment advisory subsidiary of Borea AS in Norway. Headquartered in Bergen, the firm was founded in 2005 and is owned by Trond Mohn, the Rieber, Ulstein family and employees. Borea manages alternative investment funds, mutual fund management, and provides active management and investment advice to large professional clients and wealthy private individuals.

Cambridge Consultants Ltd. develops breakthrough products. The firm specializes in innovation management, human factors and industrial design, mechanical engineering, signal processing and algorithms, sensing technologies, physical sciences, and synthetic biology. The company was founded in 1960 and is headquartered in Cambridge, the United Kingdom.

RSP Systems A/S provides non-invasive solutions for sugar and insulin blood level measurements. Its products are used to make measurements of molecules in terms of identification and quantities. The company was founded by Olav Storm Kjestrup, Stefan Banke, and Morten Henneberg in May 2006 and is headquartered in Odense, Denmark

Profil Institute for Clinical Research, Inc. operates as a full-service clinical research organization (CRO), that focuses on diabetes, obesity and NAFLD/NASH. It offers clinical development, regulatory affair, clinical research, scientific, data management and statistical, monitoring, quality and compliance, and recruitment services. The company was founded in 2004 and is headquartered in Chula Vista, CA.

B. Friele & Sønner AS engages in coffee roasting. The company was founded in 1911 and is headquartered in Bergen, Norway.

Advokatfirmaet Schjødt AS provides legal services. It offers advisory services in areas such as corporate regulation, commercial, construction, employment, labor, insolvency, restructuring, competition, and market law. The firm also offers counseling and litigation support on taxation matters, intellectual property, arbitration, dispute resolution, mergers and acquisitions, securities, custom duties, insurance, real estate, and maritime law. The company is headquartered in Oslo, Norway.

Norsk Treningshelse AS operates a training studio. The company was founded on May 29, 2018 and is headquartered in Bergen, Norway.

Odin Petroleum AS provides oil and gas exploration services. The private company is based in Straume, Norway.

Vision Co. AS develops, manufactures, and supplies vision screeners. The private company is based in Stavanger, Norway.

Novel Diagnostics AS provides biomedical research and diagnostics development services. It sells and develops medical and diagnostic products and drives commercialization of research results. The firm also invests in securities; either in form of follow-up investments in companies already has invested in, or as part of other strategic investments. The company was founded on June 10, 2002 and is headquartered in Bergen, Norway.

Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway.

Epsis AS is a holding company that specializes in development and sales of its software Epsis TeamBox. Its product is a collaboration management software solution designed to facilitate meeting workflows and sharing of information, enabling "real-time" decision making in a collaborative environment. The company was founded on June 27, 2001 and is headquartered in Kokstad, Norway.

Balter Medical AS engages in the development and commercialization of biomedical technology. Its product assists healthcare professionals in diagnosing patients with Melanoma. The company was founded by Jakob Johan Stamnes and Knut Stamnes on December 13, 2000 and is headquartered in Bergen, Norway.

Gundersen & Moldestad AS is a Norwegian company that retails hardware and wholesales plumbing supplies, heating equipment, and hardware. The private company is based in Laksevåg, Norway.

ScreenCancer AS offers cancer screening and diagnostic program to the public. It provides a panel of screening tests for several major cancers such as colorectal, bladder, breast, prostate, skin, and lung. The company was founded by Christian Horn and Dagfinn Steinar Ogreid in 2007 and is headquartered in Sola, Norway.

Sarsia Venture Management AS (SVM) is a venture capital advisory and management firm based in Bergen, Norway. They manage and advise the Sarsia Life Science Fund, established in 2005, which focuses on life science and biotechnology opportunities in the Nordic region.

Ikfe Institut für Klinische Forschung und Entwicklung GmbH is a research and development company based in Mainz, Germany. Ikfe engages in research and development in the field of natural sciences, engineering, agricultural sciences, and medicine. The German company was founded in 1998.

Part of Eli Lilly & Co., Lilly Deutschland GmbH is a pharmaceutical company based in Bad Homburg, Germany. The German company manufactures pharmaceutical products. The company was founded in 1960 by Eli Lilly. The CEO is Kadir Tepebasi.

Part of Diakard, Inc., Pfützner Science & Health Institute GmbH is a healthcare company based in Mainz, Germany. The German company offers a comprehensive service for the conception and implementation of clinical studies, fulfilling the highest quality standards while considering the individual needs of their clients. The company is led by Prof. Dr. Andreas Pfützner, a highly experienced physician and chemist with 18 years of clinical and pharmaceutical experience. Andreas Pfützner has been the CEO of the company since 2013. The company was acquired by Diakard, Inc. on January 05, 2021.

HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US.